Celgene Corporation
|
 | ||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: Just out June 29 Lancet online "Apremilast, given orally at 20 or 30 mg twice daily, seems to be efficacious, safe, and tolerable for patients with moderate to severe plaque psoriasis" One of the reasons why Celgene has been so positive on the coming Apremailast results is that they do not have to wait for these trials to be unblinded to comprehend the efficasy. A picture tells a thousand words.
|
|||||||||||||||||||
|
|
return to message board, top of board |
